Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study
Authors
Keywords
Chemotherapy-related anemia, Oral iron, IV iron, Hb response, Sucrosomial iron
Journal
SUPPORTIVE CARE IN CANCER
Volume 25, Issue 9, Pages 2779-2786
Publisher
Springer Nature
Online
2017-04-09
DOI
10.1007/s00520-017-3690-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer- and Chemotherapy-Induced Anemia
- (2017) George M. Rodgers et al. Journal of the National Comprehensive Cancer Network
- 4thMediterranean Multidisciplinary Course on Iron Anemia April 29th–30th2016, Madrid, Spain
- (2016) Sandro Barni Expert Review of Hematology
- Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data
- (2014) J Bohlius et al. BRITISH JOURNAL OF CANCER
- Anemia of Inflammation
- (2014) Elizabeta Nemeth et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial
- (2014) A. Pisani et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia
- (2014) Heinz Ludwig et al. SUPPORTIVE CARE IN CANCER
- Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia
- (2013) H. Ludwig et al. ANNALS OF ONCOLOGY
- Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia – systematic review and meta-analysis of randomised controlled trials
- (2012) Anat Gafter-Gvili et al. ACTA ONCOLOGICA
- Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron
- (2012) M. Aapro et al. ANNALS OF ONCOLOGY
- Hepcidin and iron regulation, 10 years later
- (2011) T. Ganz BLOOD
- Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials
- (2011) Fausto Petrelli et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use
- (2010) D. Schrijvers et al. ANNALS OF ONCOLOGY
- American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer
- (2010) J. Douglas Rizzo et al. Journal of Oncology Practice
- Iron supplementation and erythropoiesis-stimulatory agents in the treatment of cancer anemia
- (2009) Paolo Pedrazzoli et al. CANCER
- Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
- (2009) Julia Bohlius et al. LANCET
- Randomized Trial of Intravenous Iron Supplementation in Patients With Chemotherapy-Related Anemia Without Iron Deficiency Treated With Darbepoetin Alfa
- (2008) Paolo Pedrazzoli et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started